Proteostasis Therapeutics, Inc. (Nasdaq:PTI) to Ring The Nasdaq Stock Market Opening Bell

By , in PR PR Sci/Tech on .

ADVISORY, Dec. 15, 2017 —
What: 
Proteostasis Therapeutics, Inc. (Nasdaq:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Meenu Chhabra, President and CEO will ring the Opening Bell. Where: 
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When: 
Monday, December 18, 2017 – 9:15 a.m. to 9:30 a.m. ET           
Proteostasis Therapeutics Media Contact: 
Eliza Schleifstein, Argot Partners 
973.361.1546 
[email protected]
Nasdaq MarketSite Media Contact: 
Emily Pan
(646) 441-5120 
[email protected]
Feed Information: 
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK
Social Media: 
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: 
http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our Instagram page: 
http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our YouTube page: 
http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter page: 
http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our Tumblr page: 
http://nasdaq.tumblr.com/
Webcast:
A live stream of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos:
To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.
About Proteostasis Therapeutics, Inc. 
Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing. Headquartered in Cambridge, MA, the Proteostasis Therapeutics team focuses on identifying therapies that restore protein function. In addition to its multiple programs in cystic fibrosis, Proteostasis Therapeutics has formed a collaboration with Astellas Pharma, Inc. to research and identify therapies targeting the Unfolded Protein Response (UPR) pathway.
About Nasdaq 
Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com   
-NDAQA-

The following two tabs change content below.
Maria Burns

Maria Burns

Maria is a Viral News Editor who graduated from the University Of California. She likes social media trends, being semi-healthy, Buffalo Wild Wings and vodka with lime. When she isn’t writing, Maria loves to travel. She last went to Thailand to play with elephants and is planning a trip to Bali.
%d bloggers like this: